The 'Newly Acquired Information' Shift In Pharma Litigation
There has been a sea change in pharmaceutical litigation over the last four years. Before 2015, the key issue on which most pharmaceutical litigation generally turned was the adequacy of the...To view the full article, register now.
Already a subscriber? Click here to view full article